ChinaBio® Today Articles

Welcome to the ChinaBio® Today store. As a service to our readers, we offer access to individual articles for only $5.00 (USD) each.  Of course, a subscription is only $20/mo, so you may prefer to subscribe.  If so, click on Subscribe in the menu.

Browse


All Products

Viewing 2416 - 2430 of 5996 products
Qyuns Therapeutics Announces $20 Million Series B for Autoimmune Treatments
$5.00
Available
I-Mab and Tracon Begin US Trials of CD73 Antibody
$5.00
Available
China's United Family Healthcare Acquired by New Frontier for $1.44 Billion
$5.00
Available
Huadong Signs $60 Million Deal for MediBeacon Medical Diagnostic Devices
$5.00
Available
Zspeplib Announces $14 Million Round for Novel Peptide Drug Discovery
$5.00
Available
Xynomic to Start Two China Pivotal Trials of Novel HDAC Inhibitor
$5.00
Available
TriArm Therapeutics Completes $20 Million Series A Round for Cell Therapies
$5.00
Available
Xiamen Weiyang In-Licenses Low-Dose Interferon Alfa Technology for China
$5.00
Available
Hinova Pharma Completes $40 Million Series B for US-China Trials of Prostate Cancer Drug
$5.00
Available
Sihuan Pharma Forms JV with India's Strides, the Third China-India Pharma JV in Three Months
$5.00
Available
CANbridge Files China NDA for Hunter Syndrome Drug
$5.00
Available
Mingdu Tech Completes $14 Million Series A to Develop Efficient Pharma Programs
$5.00
Available
Qihan Raises $20 Million for Gene Editing to Enable Xenotransplants
$5.00
Available
Wanbang Biopharma In-Licenses Infant Seizure Treatment from Aucta
$5.00
Available
Innovent Tests PD-1 and Avastin Biosimilar Combo in China Lung Cancer Trial
$5.00
Available